Citations as recorded by:

1. Fetomaternal and Pediatric Toxoplasmosis

Year: 2017

Citations as recorded by: Google

2. Further evidence that naphthoquinone inhibits Toxoplasma gondii growth in vitro

Parasitology International, 2015, 64(6) p. 622

DOI: 10.1016/j.parint.2015.08.010

Citations as recorded by: Cross Ref

3. Further evidence that naphthoquinone inhibits Toxoplasma gondii growth in vitro

Year: 2015

Citations as recorded by: Google

4. Potenciais alternativas terapêuticas em estudo para a toxoplasmose congênita: Uma revisão bibliográfica

Year: 2015

Citations as recorded by: Google

5. Dihydroorotate Dehydrogenase (BboDHODH) is a Novel Molecular Target of Drug for Bovine Babesiosis

J Vet Med Sci, 2014, 76 p. 323

DOI: 10.1292/jvms.13-0419

Citations as recorded by: PMC

6. Toxoplasmosis complications and novel therapeutic synergism combination of diclazuril plus atovaquone

Front. Microbiol., 2014, 5

DOI: 10.3389/fmicb.2014.00484

Citations as recorded by: Cross Ref PMC Google

7. Maternal and congenital toxoplasmosis, currently available and novel therapies in horizon

Front. Microbiol., 2014, 5

DOI: 10.3389/fmicb.2014.00385

Citations as recorded by: Cross Ref PMC Google

8. Toxoplasmosis, Pancreatitis, Obesity and Drug Discovery

Pancreat Disord Ther, 2014, 4

Citations as recorded by: PMC Google

9. Novel Synergistic Protective Efficacy of Atovaquone and Diclazuril on Fetal-Maternal Toxoplasmosis

IJCM, 2014, 05(15) p. 921

DOI: 10.4236/ijcm.2014.515124

Citations as recorded by: Cross Ref Google

10. Diclazuril Protects against Maternal Gastrointestinal Syndrome and Congenital Toxoplasmosis

IJCM, 2014, 05(03) p. 93

DOI: 10.4236/ijcm.2014.53017

Citations as recorded by: Cross Ref PMC Google

11. Babesia bovis dihydroorotate dehydrogenase (BboDHODH) is a novel molecular target of drug for bovine babesiosis

Year: 2014

Citations as recorded by: Google